Needham Maintains Buy on Praxis Precision Medicine, Raises Price Target to $304

Benzinga · 1d ago
Needham analyst Ami Fadia maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $250 to $304.